Recent Finacing
Recent Raise
ProChon Biotech develops the BioCart autologous chondrocyte implant and FGF-based biologics for articular cartilage regeneration, conducting Phase II clinical trials, U.S. manufacturing plans, and Lonza production collaboration.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
